Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$751M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$692M |
| 3 |
Palantir
PLTR
|
+$434M |
| 4 |
Union Pacific
UNP
|
+$377M |
| 5 |
AbbVie
ABBV
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Meta Platforms (Facebook)
META
|
+$602M |
| 3 |
Bank of America
BAC
|
+$600M |
| 4 |
Wells Fargo
WFC
|
+$568M |
| 5 |
Broadcom
AVGO
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.73% |
| 2 | Financials | 7.42% |
| 3 | Healthcare | 6.65% |
| 4 | Industrials | 6.3% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
CALL
Delta Air Lines
DAL
$58.8B
| $17.1M | 0.01% |
347,900
-20,900
| -6% | -$960K |
|
|
ETOR
1677
eToro Group
ETOR
$3.02B
| $17.1M | 0.01% |
+256,910
| New | +$16.5M |
|
1678
BioCryst Pharmaceuticals
BCRX
$2.48B
| $17.1M | 0.01% |
1,906,667
-1,906,207
| -50% | -$17.8M |
|
1679
CALL
Zoom
ZM
$26.8B
| $17.1M | 0.01% |
219,000
-60,200
| -22% | -$4.65M |
|
1680
Leggett & Platt
LEG
$1.47B
| $17M | 0.01% |
1,907,642
-2,697,774
| -59% | -$23.2M |
|
1681
Microvast
MVST
$256M
| $17M | 0.01% |
4,687,392
+41,332
| +0.9% | +$121K |
|
1682
United Parks & Resorts
PRKS
$2.21B
| $17M | 0.01% |
360,172
+351,423
| +4,017% | +$15.7M |
|
1683
ESCO Technologies
ESE
$8.18B
| $17M | 0.01% |
88,413
+67,349
| +320% | +$11.5M |
|
1684
Realty Income
O
$61.3B
| $17M | 0.01% |
294,346
+249,913
| +562% | +$14.1M |
|
|
XHR
1685
Xenia Hotels & Resorts
XHR
$2.01B
| $17M | 0.01% |
1,348,484
-777,714
| -37% | -$8.9M |
|
1686
VICI Properties
VICI
$29.8B
| $16.9M | 0.01% |
519,596
+154,348
| +42% | +$4.91M |
|
1687
CALL
Lyft
LYFT
$5.87B
| $16.9M | 0.01% |
1,074,500
+623,100
| +138% | +$8.73M |
|
1688
FirstCash
FCFS
$8.97B
| $16.9M | 0.01% |
124,974
-168,776
| -57% | -$21.6M |
|
1689
PUT
Zimmer Biomet
ZBH
$18.5B
| $16.9M | 0.01% |
185,000
+164,600
| +807% | +$15.9M |
|
1690
Kenvue
KVUE
$37.9B
| $16.9M | 0.01% |
806,006
-1,275,670
| -61% | -$29M |
|
1691
CALL
Nutanix
NTNX
$16B
| $16.8M | 0.01% |
220,200
+117,900
| +115% | +$8.49M |
|
1692
Nutrien
NTR
$33.3B
| $16.8M | 0.01% |
288,682
+242,064
| +519% | +$13.7M |
|
|
AKRO
1693
DELISTED
Akero Therapeutics
AKRO
| $16.8M | 0.01% |
314,989
+84,125
| +36% | +$3.82M |
|
1694
Royalty Pharma
RPRX
$26.6B
| $16.8M | 0.01% |
466,431
+157,261
| +51% | +$5.21M |
|
|
BOW
1695
Bowhead Specialty Holdings
BOW
$1.06B
| $16.8M | 0.01% |
447,479
+197,202
| +79% | +$7.55M |
|
1696
OrthoPediatrics
KIDS
$510M
| $16.8M | 0.01% |
781,027
+124,449
| +19% | +$2.69M |
|
1697
UL Solutions
ULS
$18.5B
| $16.8M | 0.01% |
230,239
+42,049
| +22% | +$2.75M |
|
1698
Nektar Therapeutics
NKTR
$2.39B
| $16.8M | 0.01% |
649,033
+496,446
| +325% | +$5.57M |
|
1699
MannKind Corp
MNKD
$1.21B
| $16.8M | 0.01% |
4,481,526
-1,341,064
| -23% | -$5.91M |
|
1700
iShares Russell 2000 ETF
IWM
$80.4B
| $16.7M | 0.01% |
77,514
-727,104
| -90% | -$146M |
|
Similar funds
Millennium Management's Q2 2025 Portfolio in Review
As of Q2 2025, Millennium Management held 6,516 positions worth $207B, up 10% from $188B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Millennium Management's Q2 2025 filing shows 738 new, 2,295 increased, 2,418 reduced and 712 closed positions. Its largest new stake was Bank of America Series L: 164,000 shares worth $197K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.74B.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.8% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q2 2025 buy was Bank of America Series L: 164,000 shares worth $197K.
- Millennium Management added most to Applovin in Q2 2025, an estimated $751M increase.
- Millennium Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.74B.
- Millennium Management fully exited Discover Financial Services in Q2 2025, selling an estimated $282M.
- Millennium Management's ten largest holdings make up 16% of its $207B portfolio in Q2 2025.
- Millennium Management opened 738 new positions and closed 712 in Q2 2025.
- Millennium Management's portfolio value rose 10% quarter-over-quarter to $207B.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.